A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Two Doses of Ammonul (Sodium Phenylacetate and Sodium Benzoate) Injection 10%/10% in Subjects with Grade 3 or 4 Hepatic Encephalopathy
|Effective start/end date||2/1/08 → 2/4/09|
- Hyperion Therapeutics
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.